Most Read Articles
Elaine Soliven, 16 Oct 2018
The use of degludec in insulin-naïve patients with type 2 diabetes (T2D) appears to reduce HbA1c levels with a lower risk of hypoglycaemia, based on real-world data from the CONFIRM* trial presented at EASD 2018.
01 Dec 2015
More acromegalic patients presented with thyroid autoimmunity than the normal population as shown in a retrospective study.
Pearl Toh, 5 days ago
Zoledronate significantly reduces the risk of both nonvertebral and vertebral fragility fractures over 6 years in older women with osteopenia — a substantial patient group at risk for fractures but in whom a knowledge gap remains for pharmacological treatment, reveals a large randomized trial.
01 Feb 2016
The SAGIT instrument, a comprehensive clinician-reported outcome instrument, is a potential device for the assessment and management of acromegaly, based on a pilot study.

Low-intensity resistance training improves muscle strength, glycaemic function in elderly diabetics

10 Sep 2018

Low-intensity resistance training is effective at improving muscle size and strength and glycaemic function in elderly type 2 diabetes patients, a recent study has found.

Nine type 2 diabetes patients (mean age 68.2±9.7 years; 5 males) were recruited and underwent low-intensity resistance training two times a week for 16 weeks. Study outcomes included body weight, fat mass, lean body mass, knee extension and flexion strengths, and changes in fasting HbA1c levels. Wilcoxon signed-rank tests were used to evaluate the changes in outcome variables over time.

The low-intensity resistance training programme demonstrated a significant effect on several measures of body composition. For instance, mean body weight dropped significantly from 65.0±8.7 to 64.1±8.4 kg following the intervention (p=0.0499).

Similarly, significant 16-week reductions were observed for body fat mass (21.2±5.0 to 20.2±5.0 kg; p=0.012) and body fat percentage (32.8±6.8 percent to 31.5±6.6 percent; p=0.012), while significant increases were recorded for total lean body mass (63.6±6.6 percent to 64.7±6.5 percent; p=0.012) and lean body mass of the trunk (30.3±3.5 percent to 31.4±4.1 percent; p=0.017).

Significant improvements in muscle strength were also observed, both for isokinetic knee extension (angular velocity: 60o/s: 72.9±32.1 to 80.4±28.4 N·m; p=0.015; 180o/s: 46.3±17.7 to 52.7±19.6 N·m; p=0.021) and flexion (angular velocity: 60o/s: 42.7±20.7 to 50.9±20.2 N·m; p=0.012; 180o/s: 25.3±12.4 to 36.2±12.3 N·m; p=0.008).

The same was true for maximum leg press strength (62.4±19.9 to 101.2±22.7; p=0.008). In contrast, the 16-week exercise regimen had no significant effect on HbA1c (7.1±0.5 percent to 6.8±0.4 percent; p=0.066) and fasting plasma glucose (124.8±16.5 to 129.6±31.2 mg/dL; p=0.767).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 16 Oct 2018
The use of degludec in insulin-naïve patients with type 2 diabetes (T2D) appears to reduce HbA1c levels with a lower risk of hypoglycaemia, based on real-world data from the CONFIRM* trial presented at EASD 2018.
01 Dec 2015
More acromegalic patients presented with thyroid autoimmunity than the normal population as shown in a retrospective study.
Pearl Toh, 5 days ago
Zoledronate significantly reduces the risk of both nonvertebral and vertebral fragility fractures over 6 years in older women with osteopenia — a substantial patient group at risk for fractures but in whom a knowledge gap remains for pharmacological treatment, reveals a large randomized trial.
01 Feb 2016
The SAGIT instrument, a comprehensive clinician-reported outcome instrument, is a potential device for the assessment and management of acromegaly, based on a pilot study.